Publications by authors named "Martin A Cheever"

Claim this Profile
A
A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer.
Randy F Sweis, Gurkamal S Chatta, Rohit K Jain, Helen Moon, Scott Edward Delacroix, Martin A Cheever

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Kunle Odunsi, Feng Qian, Amit A Lugade, Han Yu, Melissa A Geller, Martin A Cheever

Sci Transl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.
Thomas S Uldrick, Scott V Adams, Remi Fromentin, Michael Roche, Steven P Fling, Martin A Cheever

Sci Transl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy.
Evan Greene, Greg Finak, Leonard A D'Amico, Nina Bhardwaj, Candice D Church, Martin A Cheever

Patterns (N Y)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma.
Darci Phillips, Magdalena Matusiak, Belén Rivero Gutierrez, Salil S Bhate, Graham L Barlow, Martin A Cheever

Nat Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, Shamilene Sivagnanam, David L Bajor, Martin A Cheever

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
Paul Nghiem, Shailender Bhatia, Evan J Lipson, William H Sharfman, Ragini R Kudchadkar, Martin A Cheever

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in mycosis fungoides with PD-L1 structural variants.
Sara Beygi, Sebastian Fernandez-Pol, George Duran, Erica B Wang, Henning Stehr, Martin A Cheever

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Nina Bhardwaj, Philip A Friedlander, Anna C Pavlick, Marc S Ernstoff, Brian R Gastman, Martin A Cheever

Nat Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.
Michael S Khodadoust, Alain H Rook, Pierluigi Porcu, Francine Foss, Alison J Moskowitz, Martin A Cheever

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
Thomas S Uldrick, Priscila H Gonçalves, Maher Abdul-Hay, Alisa J Claeys, Brinda Emu, Martin A Cheever

JAMA Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.
Paul Nghiem, Shailender Bhatia, Evan J Lipson, William H Sharfman, Ragini R Kudchadkar, Martin A Cheever

J Clin Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis following PD-1 blockade for cancer immunotherapy.
Daniel L Barber, Shunsuke Sakai, Ragini R Kudchadkar, Steven P Fling, Tracey A Day, Martin A Cheever

Sci Transl Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.
Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti, Jeffrey S Miller, Sylvia M Lee, Martin A Cheever

Clin Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy.
Natalie J Miller, Candice D Church, Steven P Fling, Rima Kulikauskas, Nirasha Ramchurren, Martin A Cheever

J Immunother Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors.
Jeffrey S Miller, Chihiro Morishima, Douglas G McNeel, Manish R Patel, Holbrook E K Kohrt, Martin A Cheever

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Paul T Nghiem, Shailender Bhatia, Evan J Lipson, Ragini R Kudchadkar, Natalie J Miller, Martin A Cheever

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.
Holbrook E Kohrt, Paul C Tumeh, Don Benson, Nina Bhardwaj, Joshua Brody, Martin A Cheever

J Immunother Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pillars article: Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. J. Exp. Med. 1981. 154: 952-963.
Philip D Greenberg, Martin A Cheever, Alexander Fefer

J Immunol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer.
David F Stroncek, Carolina Berger, Martin A Cheever, Richard W Childs, Mark E Dudley

J Transl Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.
Martin A Cheever, Celestia S Higano

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.
Martin A Cheever, James P Allison, Andrea S Ferris, Olivera J Finn, Benjamin M Hastings

Clin Cancer Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational Research Working Group developmental pathway for immune response modifiers.
Martin A Cheever, Jeffrey Schlom, Louis M Weiner, H Kim Lyerly, Mary L Disis

Clin Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve immunotherapy drugs that could cure cancers.
Martin A Cheever

Immunol Rev· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer.
John Nemunaitis, Thomas Meyers, Neil Senzer, Casey Cunningham, Howard West, Martin A Cheever

Mol Ther· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis